Third Harmonic Bio
Discovery Tools (Healthcare)
Third Harmonic Bio valuation and funding history | Last updated: February 16, 2022 | 1 funding rounds
Current Valuation
N/A
As of February 16, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$105.0M
Last Funding
Feb 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| February 16, 2022 | Early Stage VC (Series B) | $105.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Third Harmonic Bio is currently valued at N/A as of February 16, 2022.
What is Third Harmonic Bio Worth in 2026?
Third Harmonic Bio is a leading private company in the Discovery Tools (Healthcare) sector. Track Third Harmonic Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Third Harmonic Bio Valuation is Determined
Private company valuations like Third Harmonic Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.